Leis-Márquez MT, Rodríguez-Bosch MR, García-López MA

Language: Spanish
References: 37
Page: 461-525
PDF size: 603.28 Kb.

ABSTRACT

No abstract

REFERENCES

1. Kvale G, Olsen BE, Hinderaker SG, et al. Maternal deaths in developing countries: A preventable tragedy. Norsk Epidemiologi 2005;15:141-149.

2. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.

3. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician 2008;78:93-100.

4. Preeclampsia/Eclampsia (control del embarazo). Práctica Médica Efectiva. Instituto Nacional de Salud Pública. UNICEF-SSA/DGSR, 1999;1(7).

5. Cuadernos de Salud Reproductiva. Consejo Nacional de Población 1995-2000. Disponible en: .

6. Velasco-Murillo V, Palomares-Trejo A, Navarrete-Hernández E. Causalidad y tendencia de la mortalidad perinatal hospitalaria en el Instituto Mexicano del Seguro Social, 1998-2002. Cir Ciruj 2003;71:304-313.

7. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974-978.

8. Chambers JC, Fusi L, Malik IS, et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001;285:1607-1612.

9. Academia Nacional de Medicina. Causalidad y tendencia de la mortalidad perinatal hospitalaria en el Instituto Mexicano del Seguro Social 1998-2002.

10. Yunes J, Díaz A. Situación de la salud materno-infantil y sus tendencias en América Latina y el Caribe. PAHO Publication, WHO, 2001.

11. Villar J, Say L, Shennan A, et al. Methodological and technical issues related to the diagnosis, screening, prevention and treatment of pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2004;85(Suppl. 2):S28-S41.

12. Pérez CR, Morales HR, Doubova SV, Murillo VV. Development and use of quality of care indicators for obstetric care in women with preeclampsia, severe preeclampsia, and severe morbidity. 2007;26:241-257.

13. Greer IA. Pre-eclampsia matters. BMJ 2005;330:549-550.

14. Ellis D, Crofts JF, Hunt LP, et al. Hospital, simulation center, and teamwork training for eclampsia management: a randomized controlled trial. Obstet Gynecol 2008;111:723-731.

15. Lineamiento técnico para la prevención, diagnóstico y atención de la preeclampsia/eclampsia. Secretaría de Salud. Dirección General de Salud Reproductiva. Junio, 2002.

16. SIGN 50. A guideline developer’s handbook. Revised edition, 2008.

17. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536.

18. Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of preeclampsia on the community. BMJ 2005;330:576-580.

19. ACOG practice bulletin. Clinical management diagnosis and management of preeclampsia and eclampsia.

20. National Guideline Clearinghouse. The pre-eclampsia guideline: How to screen for and detect onset of preeclampsia in the Community Guideline, 2008.

21. Antenatal Care Guidelines. ROGC Preeclampsia, 2008;p:218-228.

22. Mendoza FME, Sánchez JB, García CM, Ávila RH. Morbilidad percibida y control prenatal. Estudio de campo. Perinatol Reprod Hum 2002;16:26-34.

23. The Society of Obstetricians and Gynaecologists of Canada. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008;30:(Suppl.1).

24. Martínez GL, Reyes FS, García PMC. Utilización adecuada de la atención prenatal en el Instituto Mexicano del Seguro Social. Salud Pub Mex 1996;38:341-351.

25. Meads CA, Cnossen JS, Meher S, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modeling. Health Technol Assess 2008;12(6):iii-iv, 1-270.

26. Guías Clínicas Fisterra. Estados hipertensivos en el embarazo 2009. Disponible en: .

27. Conde AA, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004;104:1367-1391.

28. Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008;178:701-711.

29. Christina KH, Gordon YCS, Smith, et al. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005;193:429-436.

30. Duley L, Henderson SDJ, Meher S, King JF. Agentes antiplaquetarios para la prevención de la preeclampsia y sus complicaciones. En: La Biblioteca Cochrane Plus, Cochrane Review, Issue 3, 2008.

31. Villar J, Abdel-Aleem H, Merialdi M, et al. World Health Organization Randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006;194:639-649.

32. Côté AM, Brown MA, Lam E, et al. Diagnostic accuracy of urinary spot protein: creatinine ratio for proteinuria in hypertensive pregnant women: a systematic review. BMJ 2008;336(7651):1003-1006.

33. Royal College of Obstetricians and Gynaecologists. The management of severe preeclampsia. Guideline No. 10, 2006.

34. La biblioteca de Salud Reproductiva de la OMS. Sulfato de magnesio y otros anticonvulsivos en mujeres con preeclampsia. Comentario Khalid S. Khan.

35. Duley L. Preeclampsia, eclampsia, and hypertension. BMJ Clinical Evidence. Disponible en: .

36. Lumbiganon P, Gülmezoglu AM, Piaggio G, et al. Magnesium sulfate is not used for preeclampsia and eclampsia in Mexico and Thailand as much as it should be. Bulletin of the World Health Organization 2007;85:763-767.

37. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 2007;196:514. e1-514.e9.